GLB1 and Parkinson disease: The results showed that the expression levels of GLB1, ASAH1 and PSAP in the Parkinson’s disease (PD) group were significantly higher than those in the control group, which further supports our finding that these five small molecule RNA genes (SMRGs) may be biomarkers for Parkinson’s disease.